Abstract:GATA2 coding and noncoding germline mutations cause GATA2 deficiency syndrome, often leading to myelodysplastic syndrome and acute myeloid leukemia. We demonstrated that GATA2 deficiency in murine fetal liver progenitors resulting from loss of Gata2 -77 enhancer upregulates components of Interferon-gamma (IFNg) and Toll-like receptor (TLR) signaling pathways. Using a genetic rescue system, we demonstrated that GATA2-deficient fetal progenitors are hypersensitive to IFNg and TLR1/2 agonist through signaling crosstalk to establish an aberrant transcriptional state. This elevated innate immune signaling is associated with disrupted hematopoiesis and retention of monocytic differentiation ex vivo. GATA2 deficiency elevated expression of select B-lineage and myeloid genes via a PU.1-dependent mechanism. To test the hypothesis that PU.1 is required to establish an ectopic signaling state in GATA2-deficient progenitors, we deleted Spi1 -14 kb enhancer, reducing PU.1 expression ∼50%, and tested whether PU.1 is critical, contributory, or not required for IFNg- and TLR-dependent genomic responses. RNA-seq analysis revealed that PU.1 loss abrogated TLR1/2-dependent transcriptional regulation. By contrast, PU.1 loss attenuated certain, but not all, IFNg-mediated transcriptional responses or responses to synergistic signaling. Multiomic studies are parsing GATA2 and PU.1 target genes as signal-dependent or -independent and establishing mechanisms rendering a given gene regulated by GATA2, PU.1, individual pathways, and/or synergistic signaling. In aggregate, these studies support a model in which GATA2 levels dictate genome responsiveness to the innate immune signaling milieu, and elucidating the mechanisms will unveil new concepts of how hematopoietic regulators dictate genome responsiveness to a dynamically changing signaling environment in physiological and pathologic contexts.

Identification of a human multipotent T H 2 progenitor

Terminal deoxynucleotidyl transferase and CD84 identify human multi-potent lymphoid progenitors

Tissue-specific heterogeneity of Human T follicular helper cells marked by unique transcriptomes and regulatory architecture

Identification of Early Gene Expression Changes During Human Th17 Cell Differentiation.

TCF1–LEF1 co-expression identifies a multipotent progenitor cell (T H 2-MPP) across human allergic diseases

Integrative Single-Cell Transcriptomic Analysis of Human Fetal Thymocyte Development

Genome-Wide Identification of Novel Genes Involved in Early Th1 and Th2 Cell Differentiation

ThG cells: a distinct T helper cell subset expressing GM-CSF, TNF, and IL-2, but not Th lineage-specific cytokines

Multipotent RAG1+ progenitors emerge directly from haemogenic endothelium in human pluripotent stem cell-derived haematopoietic organoids

Transcription factors TCF-1 and GATA3 are key factors for the epigenetic priming of early innate lymphoid progenitors toward distinct cell fates

Early T lymphocyte progenitors.

Temporal Gene Expression Profiles Reflect the Dynamics of Lymphoid Differentiation

Spatiotemporal Resolution of Germinal Center Tfh Cell Differentiation and Divergence from Central Memory CD4+ T Cell Fate

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms

A single cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis

3010 – MOLECULAR DETERMINANTS OF INNATE IMMUNE SIGNAL-DEPENDENT GENOME RESPONSIVENESS IN HEMATOPOIETIC PROGENITOR CELLS

Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1/2 hybrid cells

An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitors

Harnessing spatial transcriptomics to study fate decisions and lineage specification in T cell development

Tissue determinants of the human T cell receptor repertoire.